JOUNCE THERAPEUTICS, INC.: cashflow_operating
| Value | {"amount": -28877000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | current |
| Entity | JOUNCE THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:52:41.747109+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/72df1a89-b520-456d-859a-c19069db0691
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001640455-23-000024 · Open the official SEC filing →Retrieved: 2026-08-19T16:52:41.747109+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001640455/cashflow-operating/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/72df1a89-b520-456d-859a-c19069db0691
History
- no predecessors — first report